BEDFORD, Mass.–(BUSINESS WIRE)–Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to addressing the underlying cause of severe diseases by upregulating protein expression with RNA-based medicines, today announced that manageme…
Author: Business Wire
NovaBay Pharmaceuticals Closes $15.0 Million Private Placement
EMERYVILLE, Calif.–(BUSINESS WIRE)—- $NBY #DERMAdoctor–NovaBay completes $15 million financing and expects to complete acquisition of DERMAdoctor, LLC on November 5, 2021.
Talis Healthcare Teams with Wayne Health to Open Outpatient Infusion Clinic in Detroit
DETROIT–(BUSINESS WIRE)– #WayneHealth–Talis Healthcare has teamed with Wayne Health to open an outpatient infusion clinic in Midtown Detroit.
jCyte Announces Appointment of Peter C. Kuper as Senior Vice President of Finance and Information Technology
NEWPORT BEACH, Calif.–(BUSINESS WIRE)–jCyte, Inc., a private biotechnology company dedicated to improving the lives of patients with retinal degenerative diseases, announced the continued expansion of the company’s leadership team with the appointmen…
Aldeyra Therapeutics Announces Achievement of Primary Endpoint of Ocular Redness in Randomized, Double-Masked, Vehicle-Controlled Phase 2 Clinical Trial in Dry Eye Disease
LEXINGTON, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) today announced achievement of the primary endpoint of ocular redness in a randomized, double-masked, vehicle-controlled Phase 2 clinical trial in patients with dry …
Avellino Donates $25,000 to National Keratoconus Foundation to Support World Keratoconus Day and Disease Education
MENLO PARK, Calif.–(BUSINESS WIRE)– #AvaGen–Avellino donates $25,000 to the National Keratoconus Foundation to support disease education and World Keratoconus Day on November 10.
Vision Plan Satisfaction Rebounds as Doctor Visits Increase, J.D. Power Finds
TROY, Mich.–(BUSINESS WIRE)–After a decrease in overall satisfaction in 2020, vision plan satisfaction is rebounding as doctor visits increase, according to the J.D. Power 2021 U.S. Vision Plan Satisfaction Report,SM released today. Overall satisfact…
United States Market Study of Dry Eye Sufferers 2021: Attitudes Toward Prescription Medication for Becoming More Favorable – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “The 2021 Study of the U.S Market of Dry Eye Sufferers ” report has been added to ResearchAndMarkets.com’s offering. The 2021 Study of Dry Eye Sufferers focuses on both self-diagnosed and physician-diagnosed dry eye, detail…
Fabrinet Announces First Quarter Fiscal Year 2022 Financial Results
BANGKOK–(BUSINESS WIRE)– #Fabrinet–Fabrinet (NYSE: FN), a leading provider of advanced optical packaging and precision optical, electro-mechanical and electronic manufacturing services to original equipment manufacturers of complex products, today a…
Rebounding from the COVID Economy: Improving Opportunity for People with Disabilities from The National Association for the Employment of People Who Are Blind (NAEPB)
INDIANAPOLIS–(BUSINESS WIRE)–The following is an opinion editorial from Reinhard Mabry, president of The National Association for the Employment of People Who Are Blind (NAEPB) and CEO of Alphapointe in Kansas City, Mo. As we wrap up National Disabil…
Alcon #Academy21 Program to Showcase TOTAL30, Other Innovations that Meet Critical Patient and Practice Needs
FORT WORTH, Texas–(BUSINESS WIRE)–Alcon #Academy21 Program to Showcase TOTAL30, Other Innovations that Meet Critical Patient and Practice Needs
Keratoconjunctivitis Sicca (Dry Eye) Markets – Global Clinical Trials Review, H2 2021 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Keratoconjunctivitis Sicca (Dry Eye) – Global Clinical Trials Review, H2, 2021” clinical trials has been added to ResearchAndMarkets.com’s offering. “Keratoconjunctivitis Sicca (Dry Eye) – Global Clinical Trials Review, H2…
CarePlus presenta un plan de Medicare Advantage para beneficiar a los floridanos que tienen enfermedades pulmonares crónicas, incluidas las Enfermedades Pulmonares Obstructivas Crónicas (EPOC)
MIAMI–(BUSINESS WIRE)–CarePlus Health Plans, Inc., el plan de Medicare Advantage más grande* de Florida calificado con 5 de 5 estrellas para el 2022, está ampliando su oferta de planes para enfermedades crónicas, agregando CareBreeze (HMO C-SNP), un …
CarePlus Introduces Medicare Advantage Plan to Benefit Floridians with Chronic Lung Conditions, Including COPD
MIAMI–(BUSINESS WIRE)–CarePlus introduces Medicare Advantage plan to benefit Floridians with chronic lung conditions, including COPD.
NovaBay Pharmaceuticals Announces Pricing of $15.0 Million Private Placement
EMERYVILLE, Calif.–(BUSINESS WIRE)—- $NBY #Avenova–NovaBay Pharmaceuticals announces pricing of $15 million private placement to fund acquisition of DERMAdoctor, LLC.
Neurotech Pharmaceuticals Appoints Thomas Aaberg Jr., M.D. as Chief Medical Officer
CUMBERLAND, R.I.–(BUSINESS WIRE)–Neurotech Pharmaceuticals, a biotechnology company developing transformational, sight-saving therapeutics for the treatment of chronic eye diseases, announced today that Thomas Aaberg, Jr., M.D. has been appointed to …
Ocular Therapeutix™ to Present Data at the American Academy of Optometry Annual Meeting 2021
BEDFORD, Mass.–(BUSINESS WIRE)—- $OCUL #OCUTX–Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, announc…
2021 Report on the Keratoconjunctivitis Sicca Drugs In Development – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Keratoconjunctivitis sicca (Dry Eye) (Ophthalmology) – Drugs In Development, 2021” report has been added to ResearchAndMarkets.com’s offering. This report provides an overview of the Keratoconjunctivitis Sicca (Ophthalmolo…
Sam’s Club and Walmart to Launch First Eyewear Collection Created by the Legendary Elton John
BENTONVILLE, Ark.–(BUSINESS WIRE)–Elton John Eyewear, a new line of stylish, accessible eyewear, is launching at Sam’s Club today and at Walmart later this week. Elton John collaborated closely with the retailers on the development of the brand, with…
Ocular Therapeutix™ To Report Third Quarter 2021 Financial Results
BEDFORD, Mass.–(BUSINESS WIRE)—- $OCUL #OCUTX–Ocular Therapeutix™, Inc. (Nasdaq: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today…